爱游戏平台注册登录
check quantity

IVISbrite BxPC3 Red F-luc Bioluminescent Tumor Cell line (Bioware Brite)

The IVISbrite BxPC3 Red F-luc tumor cell line (Bioware® Brite BxPC3-Red-FLuc) is a light-producing cell line derived from BxPC3 human pancreatic adenocarcinoma. The cells have been stably transduced with the red-shifted firefly luciferase gene from Luciola Italica (Red F-luc), for a brighter, red-shifted signal.

For research use only. Not for use in diagnostic procedures.

貨號 BW125058
Request Technical Support

請輸入有效數量

請登錄以添加收藏夾。

購物車為空

詳細信息

IVISbrite BxPC3 Red F-luc Bioluminescent Tumor Cell line

  • Organism: Human
  • Tissue: Pancreas
  • Disease: Adenocarcinoma
  • Optical Reporter: Red F-luc

This cell line has very bright bioluminescence, emitting at least 15,000 photons/cell/sec in vitro. The exact number will vary depending on imaging and culturing conditions.

By emitting intensified, longer wavelength light that is significantly brighter than other firefly luciferases, our bioluminescent oncology cell lines allow you to visualize and monitor the growth of deep tissue tumors in vivo.

After the cells are injected into an appropriate mouse model, the optimized Red F-luc luciferase enables more sensitive in vivo optical detection with less tissue attenuation so you can detect tumor development earlier, and monitor tumor growth and metastases in both subcutaneous and orthotopic models.

規格

腫瘤細胞係 Pancreatic
熒光素酶分類 Firefly
產品品牌名稱 IVISbrite
包裝量 2.0 Vials
運輸條件 幹冰
產品尺寸 2 million cells
資源
  • 所有

Ebook

了解更多請點擊下載小動物活體成像解決方案

Researchers trust our in vivo imaging solutions to give them reliable, calibrated data that reveals pathway characterization and therapeutic efficacies for a broad range of indications. Our reagents, instruments, and applications support have helped hundreds of research projects over the years. And ...

PDF 4 MB

產品手冊

In Vivo Imaging Reagents

Our comprehensive range of bioluminescent and fluorescent imaging reagents provide researchers with the necessary tools to better understand early disease-related biological changes, track disease progression, help guide the drug discovery process, and evaluate efficacy and safety of drug candida ...

PDF 1 MB

指南

IVISense™ Fluorescent Probe Selector Guide for Oncology Research

The goal of in vivo fluorescence molecular imaging is to enable non-invasive visualization and quantification of cellular and biological functioning to better understand and characterize disease processes and treatment effects earlier within the context of a biological system.

This s ...

PDF 4 MB

白皮書

The Role of In Vivo Imaging in Drug Discovery and Development

The primary goal of preclinical imaging is to improve the odds of clinical success and reduce drug discovery and development time and costs. Advances in non-invasive in vivo imaging techniques have raised the use of animal models in drug discovery and development to a new level by enabling quick ...

PDF 547 KB
Baidu
map